- Home
- VNDA vs OPRT Comparison
VNDA vs OPRT Comparison
Compare VNDA & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- OPRT
- Stock Information
- Founded
- VNDA 2002
- OPRT 2005
- Country
- VNDA United States
- OPRT United States
- Employees
- VNDA N/A
- OPRT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- OPRT Finance: Consumer Services
- Sector
- VNDA Health Care
- OPRT Finance
- Exchange
- VNDA Nasdaq
- OPRT Nasdaq
- Market Cap
- VNDA 249.4M
- OPRT 290.9M
- IPO Year
- VNDA 2006
- OPRT 2019
- Fundamental
- Price
- VNDA $4.51
- OPRT $6.65
- Analyst Decision
- VNDA Strong Buy
- OPRT Hold
- Analyst Count
- VNDA 2
- OPRT 2
- Target Price
- VNDA $16.50
- OPRT $8.00
- AVG Volume (30 Days)
- VNDA 404.6K
- OPRT 650.0K
- Earning Date
- VNDA 11-05-2025
- OPRT 11-11-2025
- Dividend Yield
- VNDA N/A
- OPRT N/A
- EPS Growth
- VNDA N/A
- OPRT N/A
- EPS
- VNDA N/A
- OPRT N/A
- Revenue
- VNDA $203,467,000.00
- OPRT $724,757,000.00
- Revenue This Year
- VNDA $15.45
- OPRT $27.48
- Revenue Next Year
- VNDA $37.82
- OPRT $5.29
- P/E Ratio
- VNDA N/A
- OPRT N/A
- Revenue Growth
- VNDA 11.78
- OPRT N/A
- 52 Week Low
- VNDA $3.81
- OPRT $2.37
- 52 Week High
- VNDA $5.55
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- VNDA 46.90
- OPRT 55.55
- Support Level
- VNDA $4.54
- OPRT $6.14
- Resistance Level
- VNDA $4.64
- OPRT $6.95
- Average True Range (ATR)
- VNDA 0.15
- OPRT 0.33
- MACD
- VNDA -0.01
- OPRT 0.02
- Stochastic Oscillator
- VNDA 8.89
- OPRT 70.59
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.